GeminIQ Website Logo

Viewing VANI free

Subscribe for full history, 90+ metrics, screener, watchlist...

Vivani Medical, Inc.

VANI

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Cash And Cash Equivalents At Carrying Value
2020163713182025302125
Assets Current
Assets Current
2222184915202126322331
Receivables Net Current
-0----------
Prepaid Expense And Other Assets Current
111112221226
Property Plant And Equipment Net
333322222221
Operating Lease Right Of Use Asset
161717171718181819192020
Restricted Cash And Cash Equivalents Noncurrent
------1---1-
Restricted Cash Noncurrent
--1---1-----
Other Assets Noncurrent
11-111-11111
Assets
424239252935424348544653
Liabilities And Stockhold…
Accounts Payable Current
111121111112
Accrued Liabilities Current
222222222222
Liabilities Current
Liabilities Current
777776666667
Litigation Reserve Current
222222222222
Employee Related Liabilities Current
000000000101
Operating Lease Liability Current
222111111111
Operating Lease Liability Noncurrent
161617171718181819191920
Liabilities
232324242424242524252527
Common Stock Value
000000000000
Stockholders Equity
Stockholders Equity
1919161512181824292126
Additional Paid In Capital
181174164143140140139134134133119119
Accumulated Other Comprehensive Income Loss Net Of…
000000000000
Retained Earnings Accumulated Deficit
-162-155-149-142-135-128-122-116-110-104-98-92
Liabilities And Stockholders Equity
424239252935424348544653
Preferred Stock Par Or Stated Value Per Share
--0000000000
Common Stock No Par Value
000000000000
Preferred Stock Shares Authorized
-1010101010101010101010
Preferred Stock Shares Outstanding
--0000000000
Common Stock Shares Authorized
300300300300300300300300300300300300
Common Stock Shares Issued
898576625959595555555151
Shares Outstanding
898576625959595555555151

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20261.72%8.62%10.34%---------
20259.52%20.00%26.67%2.38%11.11%27.78%3.32%-6.27%2.58%24.07%8.33%1.85%
2024-12.70%-33.51%-35.14%0.86%1.72%11.21%-4.32%-7.91%-14.39%0.00%7.62%20.00%
2023----21.31%-15.57%-12.30%-8.24%2.94%0.98%-9.57%6.12%-14.89%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
3.25
3.18
2.71
0.61
1.30
2.40
3.41
3.41
4.55
5.13
4.03
4.13
Quick Ratio
3.09
3.02
2.56
0.48
1.09
2.13
3.11
3.13
4.31
4.83
3.61
3.34
Working Capital
14.98M
14.77M
11.30M
-2.66M
2.00M
8.65M
14.46M
15.13M
20.55M
25.36M
17.34M
23.25M
Leverage & Debt
Debt to Equity
1.20
1.22
1.50
18.13
4.89
2.05
1.36
1.34
1.02
0.87
1.21
1.03
Debt Ratio
0.54
0.55
0.60
0.95
0.83
0.67
0.58
0.57
0.51
0.47
0.55
0.51
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Receivables Turnover TTM
-
0.00
-
-
-
-
-
-
-
-
-
-
Per Share Metrics
Diluted EPS TTM
-0.30
-0.33
-0.43
-0.44
-0.43
-0.40
-0.43
-0.42
-0.44
-0.49
-0.50
-0.53
Free Cash Flow Per Share TTM
-0.30
-0.33
-0.41
-0.41
-0.39
-0.37
-0.39
-0.35
-0.39
-0.43
-0.48
-0.50
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Growth Metrics
Net Revenue Growth (1Y)
-
-
-
-
-
-
-
-
-
-
-100.00%
-100.00%
Net Income Growth (1Y)
3.04%
14.06%
13.30%
10.93%
5.51%
-6.40%
-8.44%
-12.82%
29.39%
55.83%
84.69%
150.36%
EPS Growth (1Y)
-29.91%
-16.87%
-0.16%
2.64%
-2.01%
-17.52%
-15.32%
-19.78%
19.45%
51.51%
84.27%
86.97%
Valuation Metrics
P/E TTM
-4.10
-3.00
-2.88
-3.23
-2.99
-2.62
-2.72
-2.76
-2.86
-3.81
-2.02
-1.93
P/B TTM
5.69
4.26
4.88
64.32
15.57
5.35
3.62
3.53
2.91
3.36
2.50
1.98
Market Cap
107.99M
81.27M
76.74M
84.19M
76.42M
62.20M
63.78M
64.64M
69.33M
96.57M
51.87M
51.85M
Enterprise Value
88.10M
61.52M
60.51M
81.56M
69.63M
49.19M
44.09M
44.99M
44.41M
66.93M
29.88M
27.03M
Calculated Values
Free Cash Flow TTM
-26.50M
-26.52M
-25.49M
-24.61M
-23.14M
-21.82M
-21.34M
-19.46M
-21.52M
-22.28M
-24.59M
-25.65M
Net Debt
-19.89M
-19.75M
-16.23M
-2.63M
-6.79M
-13.01M
-19.69M
-19.65M
-24.92M
-29.65M
-21.99M
-24.82M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-15Purchase
Owner: Williams, Gregg
Title: -
Shares: 1,587,301
Price/Share: $1.26
Value: $1,999,999.26
Shares Owned: 36,119,086
Relationship: Director,TenPercentOwner
Ownership: Indirect
2026-05-15Purchase
Owner: Williams, Gregg
Title: -
Shares: 1,587,301
Price/Share: $1.26
Value: $1,999,999.26
Shares Owned: 34,531,785
Relationship: Director,TenPercentOwner
Ownership: Indirect
2026-04-15Purchase
Owner: Williams, Gregg
Title: -
Shares: 1,587,301
Price/Share: $1.26
Value: $1,999,999.26
Shares Owned: 32,944,484
Relationship: Director,TenPercentOwner
Ownership: Indirect
2026-03-15Purchase
Owner: Williams, Gregg
Title: -
Shares: 1,575,231
Price/Share: $1.14
Value: $1,795,763.34
Shares Owned: 31,357,183
Relationship: Director,TenPercentOwner
Ownership: Indirect
2026-02-15Purchase
Owner: Williams, Gregg
Title: -
Shares: 1,866,492
Price/Share: $1.14
Value: $2,127,800.88
Shares Owned: 29,781,952
Relationship: Director,TenPercentOwner
Ownership: Indirect

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
6.37%
Inst. Shares: 5,178,312
Shares Outstanding: 81,269,000
2025-12-31
7.28%
Inst. Shares: 4,541,670
Shares Outstanding: 62,389,000
2025-09-30
6.01%
Inst. Shares: 3,585,672
Shares Outstanding: 59,711,000
2025-06-30
6.28%
Inst. Shares: 3,721,932
Shares Outstanding: 59,244,000
2025-03-31
7.47%
Inst. Shares: 4,425,086
Shares Outstanding: 59,236,000

Vivani Medical, Inc. (VANI) — SEC Financial Statements & Analysis

Vivani Medical, Inc. (VANI) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. Vivani Medical, Inc. trades on Nasdaq as: VANI. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Vivani Medical, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 1.20x, a Price-to-Book (P/B) ratio of 5.69x (TTM), at a market cap of $107.99M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-100.00%
Debt To Equity
1.20x
P/B TTM
5.69x
Market Cap
$107.99M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Vivani Medical, Inc. in?

Vivani Medical, Inc. (VANI) operates in the Electromedical & Electrotherapeutic Apparatus industry.

What is VANI's market cap?

Vivani Medical, Inc. (VANI) has a market capitalization of $107.99M as of 2026-06-30.

What exchange does VANI trade on?

Vivani Medical, Inc. (VANI) trades on the Nasdaq.

Where is Vivani Medical, Inc. incorporated?

Vivani Medical, Inc. is incorporated in DE.

Wall Street's data.
Main Street's price.